Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yida Biotechnology represents a group of regional Chinese biotechnology enterprises specializing in bioprocessing, industrial enzymes, healthcare ingredients, and life science tools. Key entities include Beijing Yida Enzyme Biotechnology Co., Ltd., which provides enzyme preparations and microbial strains for food, agriculture, and daily chemicals; Nanjing Yida Biotechnology Co., Ltd., focused on food additives and algae deep processing; Yantai Yida Biotechnology Co., Ltd., a manufacturer of collagen peptides and nutritional supplements; and Suzhou Yida Biotechnology Co., Ltd., which develops electroporation systems for cell transfection. Together, these companies serve global markets with bio-based products, ingredients, and laboratory equipment. Because their business models center on manufacturing, trading, and research instrumentation rather than therapeutics, they do not possess a clinical drug development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yida Biotechnology.